Price inflation continues to come in above the two-percent target, seven months after Fed economists wrongly predicted that ...

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

Shimano's potential in E-Bikes and China supports a Hold rating, despite risks like a Q2'25 topline miss. Read here for an ...

Baidu (BIDU) has announced the appointment of Haijian He as CFO of the company, effective immediately. Concurrently, ...

Renault Group (RNSDF) on Tuesday said it would record a €9.5 billion ($11.2 billion) non-cash loss in the first half of the ...

Texas Instruments' stock is overvalued with high risks from heavy Capex, rising debt, and competition. Learn why TXN stock is ...

TJX's off-price model drives growth amid challenges. International expansion is showing improving profitability. Read an ...

BYD's growth is decelerating, due to rising competition in China and macro headwinds. Read why a prolonged sideways movement ...

GOAU's high valuation and fees may outweigh its benefits. Understand the risks of investing late in the gold bull market.

Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. Read what BMY stock has to offer ...

Canyon Resources (OTCPK:CYRWF) has announced that Peter Secker officially began his role as CEO, effective today. This ...

Alimentation Couche-Tard is rated Hold amid US macro headwinds, rising costs, and near-term challenges affecting earnings ...